Healthcare deals specialist Jason Zemmel will be based in London | 3w
Healthcare deals specialist Jason Zemmel will be based in London | 3w
The long-running IP dispute related to the Nobel Prize-winning gene editing technology CRISPR rumbles on and now extends beyond ownership, write HSF lawyers Emily Bottle and Dylan Churchill | 3w
Plaintiff lawyer David Kessler was lead counsel in landmark Tyco class action | 3w
Sale to US private equity firm Clayton Dubilier & Rice comes as investors anticipate more and larger European PE buyouts | 4w
Historic attitudes favouring globalisation are fundamentally changing. | 1yr
Editor:
Californian court finds ‘strong likelihood’ that ex-employee took trade secret information to benefit his own company | 4w
Latest lawsuits in mounting patent litigation over vaccines against the two viruses | 1mo
Arrival of Tim Powell continues US firm’s European IP push | 1mo
GSK’s two patents declared invalid as both attempt to launch first RSV vaccine in UK market | 1mo
Novartis and Genentech had accused Korean rival of “imminent infringement” through marketing of biosimilar | 2mos
Charles Atkinson to replace Todd Kingma, who retires from Perrigo for a second time | 2mos
Veteran IP litigator Hiroshi Sheraton and M&A lawyer Luciana Griebel join in London | 2mos
The way the request was processed still raises ‘significant concerns’, says the firm | 2mos
Alexander Klett, Christoph Mikyska and Sebastian Dexheimer move over from Reed Smith and Milbank | 3mos
Pan-European patent court delivers first revocation judgment a year and a month after opening | 4mos
Any regulatory changes to drug patents and pricing should be wary of stifling innovation, writes Neal Gerber Eisenberg lawyer Thomas Campbell | 4mos
Trio of partners join from Wilson Sonsini and boutique Hooper Lundy & Bookman as Orrick continues life sciences push | 4mos
Glucose monitoring patent revoked across 17 UPC member states in ongoing dispute with rival Abbott | 4mos
Mathys & Squire patent litigator Stephen Garner discusses changes to EU pharmaceutical legislation and the impact on IP rights | 4mos
Freshfields, Taylor Wessing and Powell Gilbert advise on closely watched London High Court dispute | 4mos
Swedish companies are imposing age restrictions on their beauty products. Bird & Bird lawyers Caroline Grotenfelt, Julia Jansson and Beatrice Rälg ask if more countries will follow suit? | 5mos